Atea Pharmaceuticals Inc
NASDAQ:AVIR

Watchlist Manager
Atea Pharmaceuticals Inc Logo
Atea Pharmaceuticals Inc
NASDAQ:AVIR
Watchlist
Price: 3.62 USD 5.54%
Market Cap: 282.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of AVIR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AVIR Intrinsic Value
Not Available
Base Case Scenario
Compare AVIR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AVIR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Atea Pharmaceuticals Inc

Current Assets 336.1m
Cash & Short-Term Investments 329.3m
Other Current Assets 6.8m
Non-Current Assets 6.8m
PP&E 1.4m
Other Non-Current Assets 5.5m
Current Liabilities 20.2m
Accounts Payable 3.5m
Accrued Liabilities 16.7m
Non-Current Liabilities 7m
Other Non-Current Liabilities 7m
Efficiency

Free Cash Flow Analysis
Atea Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Atea Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-160m USD
Operating Income
-160m USD
Other Expenses
12.9m USD
Net Income
-147m USD
Fundamental Scores

AVIR Profitability Score
Profitability Due Diligence

Atea Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Net Margin
Low 3Y Average Gross Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Atea Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

AVIR Solvency Score
Solvency Due Diligence

Atea Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Atea Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AVIR Price Targets Summary
Atea Pharmaceuticals Inc

Wall Street analysts forecast AVIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVIR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
67% Upside
Average
Price Target
6.12 USD
69% Upside
Highest
Price Target
6.3 USD
74% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Atea Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AVIR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AVIR Insider Trading
Buy and sell transactions by insiders

AVIR News

Other Videos